Johns Hopkins researchers discover new mechanism for human visual acuity development

Researchers at Johns Hopkins University have identified a new biological mechanism that explains how sharp human vision develops during embryonic stages. The study, published in the Proceedings of the National Academy of Sciences (PNAS), challenges a 30 year old theory regarding retinal development.

Using lab-grown human retinal organoids, the team observed that certain blue-light-sensitive cone cells undergo a transformation during fetal development. Between the tenth and twelfth weeks, blue-sensitive cells appear, but by approximately the fourteenth week, some of these cells transition into red and green light-sensitive cells. This process is essential for forming the fovea, the area of the retina responsible for high-resolution central vision.

The study highlights a dual-action process: retinoic acid, a derivative of vitamin A, helps establish the initial cell pattern, while thyroid hormones drive the subsequent cellular transformation. This discovery contradicts previous assumptions that blue cones simply migrated to different parts of the retina without changing their function.

While the findings do not suggest that vitamin A supplements improve vision in adults, they offer significant potential for medical research. Understanding these developmental pathways may lead to new treatments for retinal diseases, such as age-related macular degeneration, by exploring ways to replace damaged cells with lab-grown light-sensitive cells.